Christopher Benecchi

Christopher Benecchi appears in our data through filings on Sage Therapeutics, Inc. shares, published by SEC (Form 4). Between 3 February 2023 and 31 July 2025, the trades on record add up to 8 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 31 July 2025, the filings show a transaction in Sage Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.